Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) Sets New 12-Month High – What’s Next?

Posted by Doug Wharley on Apr 3rd, 2025

Shares of Fresenius SE & Co. KGaA (OTCMKTS:FSNUY – Get Free Report) hit a new 52-week high during trading on Thursday . The company traded as high as $11.28 and last traded at $10.94, with a volume of 27479 shares traded. The stock had previously closed at $10.76.

Analysts Set New Price Targets

Separately, Deutsche Bank Aktiengesellschaft reiterated a “buy” rating on shares of Fresenius SE & Co. KGaA in a report on Monday, February 3rd.

View Our Latest Research Report on Fresenius SE & Co. KGaA

Fresenius SE & Co. KGaA Stock Performance

The company has a debt-to-equity ratio of 0.57, a current ratio of 1.36 and a quick ratio of 1.05. The company has a market cap of $24.45 billion, a price-to-earnings ratio of 52.11 and a beta of 0.86. The firm has a 50 day simple moving average of $10.24 and a 200-day simple moving average of $9.47.

Fresenius SE & Co. KGaA (OTCMKTS:FSNUY – Get Free Report) last issued its quarterly earnings data on Wednesday, February 26th. The company reported $0.18 earnings per share (EPS) for the quarter. The company had revenue of $6.01 billion during the quarter. As a group, analysts predict that Fresenius SE & Co. KGaA will post 0.79 EPS for the current fiscal year.

About Fresenius SE & Co. KGaA

(Get Free Report)

Fresenius SE & Co KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure.